Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An observational, cross-sectional, multicenter study assessing the quality of life (QoL) and health care resource utilization of patients being prescribed with sacubitril/valsartan in Portugal

Next Previous
Search
Trial Profile

An observational, cross-sectional, multicenter study assessing the quality of life (QoL) and health care resource utilization of patients being prescribed with sacubitril/valsartan in Portugal

Status: Recruiting
Phase of Trial: Phase IV

Latest Information Update: 19 Nov 2020

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 19 Nov 2020 Results (n=285; as of July 2020) assessing persistence of sacubitril/valsartan in a real-world setting of heart failure (HF) patients at 12 months, presented at the 23rd Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research.
  • 06 Nov 2019 Results (n=262; as of May 2019) assessing the prescription patterns and titration of Sacubitril/Valsarta were presented at the 22nd Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research
  • 06 Nov 2019 Results assessing the robustness of self-assessed NYHA by correlating it with patients HF symptoms presented at the 22nd Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top